ClinicalTrials.Veeva

Menu

Effects of Invisalign Palatal Expander System

University of the Pacific logo

University of the Pacific

Status

Enrolling

Conditions

Palatal Expansion Technique

Treatments

Device: HE
Device: IPE

Study type

Interventional

Funder types

Other

Identifiers

NCT06414863
2024-43

Details and patient eligibility

About

The aim of this study is to evaluate the effectiveness of Invisalign Palatal Expander system ingrowing patients. This study compares the treatment outcomes of Invisalign Palatal Expander system to conventional treatments through randomized controlled trial.

Enrollment

120 estimated patients

Sex

All

Ages

6 to 14 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Mixed dentition phase with at least three nonmobile (stable) teeth which have more than 1/4 of primary molar root length left16 in either side
  2. Early permanent dentition stage and early permanent dentition but second permanent molars not yet fully erupted in the arch
  3. Unilateral or bilateral posterior cross bite patients; or Patients who have been diagnosed with transverse maxillary deficiency (Skeletal transverse discrepancy measured from the estimated center of resistances of the first molars17 ≤ - 3 mm);
  4. Patients with Class I or Class II skeletal relationship
  5. Subjects willing to consent to the trial

Exclusion criteria

  1. Any general medical health problems which may influence treatment
  2. Any craniofacial anomalies
  3. Skeletal Class III patients
  4. Mixed dentition patients with more than 2 heavily restored primary second or permanent first molars.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

120 participants in 2 patient groups

Invisalign® Palatal Expander System
Experimental group
Description:
Invisalign® Palatal Expander System will be delivered.
Treatment:
Device: IPE
Hyrax-type maxillary expander
Active Comparator group
Description:
Hyrax-type maxillary expander will be delivered. The Hyrax-type maxillary expander will include a midline self-locking screw, which is connected to the conventional molar bands or printed clasps, which are cemented on the maxillary first molars (or on the maxillary primary second molars), via 0.9 mm stainless-steel wire. The framework is soldered to the bands and extends on the palatal side to the primary canines or canines. The expander will be fabricated by a qualified laboratory technician
Treatment:
Device: HE

Trial contacts and locations

1

Loading...

Central trial contact

Heeyeon Suh

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems